Bio‑Rad welcomes you to attend the 3rd Annual Downstream Purification Symposium at Institute for Bioscience and Biotechnology Research. This event will include discussion of new developments in purification of biologics and key industry regulatory topics. Thursday, May 9, 2019
9:00 AM–5:00 PM
Location
Institute for Bioscience & Biotechnology Research
9600 Gudelsky Drive
Rockville, MD 20850
The Small Business Administration (SBA) has statutory authority to establish federal Government-wide policies to implement the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. SBA recently issued a significantly revised final SBIR/STTR Policy Directive, which is effective May 2, 2019. See 84 FR 12794. Below we highlight the major changes implemented in the revised policy directive.
Most recently, the biotech executive helmed one of the fastest-growing public companies in Baltimore last year.
An argument has been brewing on Capitol Hill and elsewhere that boils down to the theory that US taxpayers are fronting billions of dollars’ worth of public research that translates into early-stage products that are later sold to companies, go on to win FDA approval and then reap millions or billions in sales, although the government never sees a dime of those earnings.
The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces 12 finalists that will present at the “Make Your Medical Device Pitch for Kids!” competition on April 30, 2019 at the University of Maryland, College Park. The finalists, all innovators in the orthopedic and spine sector, have a chance to win up to $50,000 in grant funding and access to the newly created NCC-PDI “Pediatric Device Innovator Accelerator Program” led by MedTech Innovator.
Are you excited about the work you do in the biohealth industry? How did you get to where you are? Would you like to be connected to the newest career ready talent pool?
Join us for a Happy Hour with post docs from NCI and other NIH institutes who have expressed interest in transitioning to our exciting industry! Help them learn about your work and opportunities in the field. You may find one of your best future hires in the process!
These events are being cohosted by BioHealth Innovation, American Gene Technologies and SciPhD. The events are free but registration is required.
Postdoc Industry Connections Happy Hour
5/8 – 5-6:30 p.m. – American Gene Technologies
9640 Medical Center Dr Rockville, MD 20850
Were you unable to attend the 2019 BioHealth Capital Region Forum? Are you looking to stay updated on what is happening with Companies/Organizations/Institutions in the BHCR throughout the year? Be sure to bookmark http://www.biohealthcapital.com/ in your internet browsers today to keep yourself in the loop. From a look back at the Forum Agenda to News on Companies in the Region, the BHCR website is one of your go-to pages along with http://www.biohealthinnovation.org/.
Do you have news to share in the region? Be sure to let us know by tagging on social media! @BiohealthCR on Twitter. We can also be found on Facebook and LinkedIn!
GlycoMimetics, Inc. (NASDAQ: GLYC) today announced the publication of a paper in Nature Cell Biology that describes how tumor cells engage specific stromal components, most notably E-selectin, for propagation and outgrowth.1 The paper provides further scientific support for the clinical trial in breast cancer patients with bone metastasis that was recently announced by GlycoMimetics.
The Food and Drug Administration (FDA) on Friday announced that it granted final approval to the first generic naloxone hydrochloride nasal spray, which can be used to reverse opioid overdoses.
The Golden State is living up to its nickname, with California ranking as the most innovative economy in America.
That’s according to Bloomberg’s newest U.S. State Innovation Index based on six equally-weighted metrics: research and development intensity, productivity, clusters of companies in technology, “STEM” jobs, populous with degrees in science and engineering disciplines, and patent activity.
